{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:36:05Z","timestamp":1787726165530,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dengue is a widespread viral disease with 3.6 billion people at risk worldwide. Humanized monoclonal antibody (mAb) 513, currently undergoing clinical trials in Singapore, targets an epitope on the envelope protein domain III exposed at the surface of the viral particle. This antibody potently neutralizes all four dengue virus serotypes in a humanized mouse model that recapitulates human dengue infection, without signs of antibody-mediated enhancement of the disease. The crystal structure of single-chain variable fragment (scFv) 513 bound to the envelope protein domain III from dengue virus serotype 4 was used as a template to explore the molecular origins of the broader cross-reactivity and increased <jats:italic>in vivo<\/jats:italic> potency of mAb 513, compared to the parent murine mAb 4E11, using molecular dynamics simulations and network analyses. These two methods are a powerful complement to existing structural and binding data and detail specific interactions that underpin the differential binding of the two antibodies. We found that a Glu at position H55 (Glu<jats:sup>H55<\/jats:sup>) from the second Complementarity Determining Region of the Heavy chain (CDR-H2) which corresponds to Ala in 4E11, is a major contributor to the enhancement in the interactions of mAb 513 compared to 4E11. Importantly, we also validate the importance of Glu<jats:sup>H55<\/jats:sup> using site-directed mutagenesis followed by isothermal titration calorimetry measurements.<\/jats:p>","DOI":"10.1038\/s41598-018-26800-y","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T10:09:05Z","timestamp":1527242945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513"],"prefix":"10.1038","volume":"8","author":[{"given":"Yee Hwa","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshita","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Wai","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannan","family":"Tharakaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9539-5249","authenticated-orcid":false,"given":"Kannan","family":"Srinivasaraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Sasisekharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Lescar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,31]]},"reference":[{"key":"26800_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nrmicro3430","volume":"13","author":"JP Messina","year":"2015","unstructured":"Messina, J. P. et al. The many projected futures of dengue. Nat Rev Microbiol 13, 230\u2013239, https:\/\/doi.org\/10.1038\/nrmicro3430 (2015).","journal-title":"Nat Rev Microbiol"},{"key":"26800_CR2","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.cell.2015.07.005","volume":"162","author":"MS Diamond","year":"2015","unstructured":"Diamond, M. S. & Pierson, T. C. Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control. Cell 162, 488\u2013492, https:\/\/doi.org\/10.1016\/j.cell.2015.07.005 (2015).","journal-title":"Cell"},{"key":"26800_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504\u2013507, https:\/\/doi.org\/10.1038\/nature12060 (2013).","journal-title":"Nature"},{"key":"26800_CR4","unstructured":"WHO. Dengue and severe dengue, http:\/\/www.who.int\/mediacentre\/factsheets\/fs117\/en\/-.Wl16veR0PqY.link (2017)."},{"key":"26800_CR5","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","volume":"373","author":"SR Hadinegoro","year":"2015","unstructured":"Hadinegoro, S. R. et al. Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. New England Journal of Medicine 373, 1195\u20131206, https:\/\/doi.org\/10.1056\/NEJMoa1506223 (2015).","journal-title":"New England Journal of Medicine"},{"key":"26800_CR6","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1126\/science.101.2634.640","volume":"101","author":"AB Sabin","year":"1945","unstructured":"Sabin, A. B. & Schlesinger, R. W. Production of Immunity to Dengue with Virus Modified by Propagation in Mice. Science 101, 640\u2013642, https:\/\/doi.org\/10.1126\/science.101.2634.640 (1945).","journal-title":"Science"},{"key":"26800_CR7","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","volume":"384","author":"MR Capeding","year":"2014","unstructured":"Capeding, M. R. et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 384, 1358\u20131365, https:\/\/doi.org\/10.1016\/S0140-6736(14)61060-6 (2014).","journal-title":"Lancet"},{"key":"26800_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1411037","volume":"372","author":"L Villar","year":"2015","unstructured":"Villar, L. et al. Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America. New England Journal of Medicine 372, 113\u2013123, https:\/\/doi.org\/10.1056\/NEJMoa1411037 (2015).","journal-title":"New England Journal of Medicine"},{"key":"26800_CR9","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/infdis\/jiv179","volume":"212","author":"SL George","year":"2015","unstructured":"George, S. L. et al. Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial. J Infect Dis 212, 1032\u20131041, https:\/\/doi.org\/10.1093\/infdis\/jiv179 (2015).","journal-title":"J Infect Dis"},{"key":"26800_CR10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/infdis\/jiv082","volume":"212","author":"BD Kirkpatrick","year":"2015","unstructured":"Kirkpatrick, B. D. et al. Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults. J Infect Dis 212, 702\u2013710, https:\/\/doi.org\/10.1093\/infdis\/jiv082 (2015).","journal-title":"J Infect Dis"},{"key":"26800_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0168-1656(99)00037-1","volume":"69","author":"P Thullier","year":"1999","unstructured":"Thullier, P. et al. A recombinant Fab neutralizes dengue virus in vitro. Journal of biotechnology 69, 183\u2013190 (1999).","journal-title":"Journal of biotechnology"},{"key":"26800_CR12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1099\/vir.0.006874-0","volume":"90","author":"R Rajamanonmani","year":"2009","unstructured":"Rajamanonmani, R. et al. On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes. J Gen Virol 90, 799\u2013809, https:\/\/doi.org\/10.1099\/vir.0.006874-0 (2009).","journal-title":"J Gen Virol"},{"key":"26800_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","volume":"8","author":"M Beltramello","year":"2010","unstructured":"Beltramello, M. et al. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 8, 271\u2013283, https:\/\/doi.org\/10.1016\/j.chom.2010.08.007 (2010).","journal-title":"Cell Host Microbe"},{"key":"26800_CR14","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.4049\/jimmunol.1200227","volume":"188","author":"CM Midgley","year":"2012","unstructured":"Midgley, C. M. et al. Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity. J Immunol 188, 4971\u20134979, https:\/\/doi.org\/10.4049\/jimmunol.1200227 (2012).","journal-title":"J Immunol"},{"key":"26800_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.str.2012.01.001","volume":"20","author":"JJ Cockburn","year":"2012","unstructured":"Cockburn, J. J. et al. Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody. Structure 20, 303\u2013314, https:\/\/doi.org\/10.1016\/j.str.2012.01.001 (2012).","journal-title":"Structure"},{"key":"26800_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cell.2015.06.057","volume":"162","author":"LN Robinson","year":"2015","unstructured":"Robinson, L. N. et al. Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope. Cell 162, 493\u2013504, https:\/\/doi.org\/10.1016\/j.cell.2015.06.057 (2015).","journal-title":"Cell"},{"key":"26800_CR17","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","volume":"328","author":"W Dejnirattisai","year":"2010","unstructured":"Dejnirattisai, W. et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 328, 745\u2013748, https:\/\/doi.org\/10.1126\/science.1185181 (2010).","journal-title":"Science"},{"key":"26800_CR18","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1099\/0022-1317-82-8-1885","volume":"82","author":"P Thullier","year":"2001","unstructured":"Thullier, P. et al. Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism. J Gen Virol 82, 1885\u20131892, https:\/\/doi.org\/10.1099\/0022-1317-82-8-1885 (2001).","journal-title":"J Gen Virol"},{"key":"26800_CR19","doi-asserted-by":"publisher","first-page":"E1555","DOI":"10.1073\/pnas.1303645110","volume":"110","author":"K Tharakaraman","year":"2013","unstructured":"Tharakaraman, K. et al. Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency. Proc Natl Acad Sci USA 110, E1555\u20131564, https:\/\/doi.org\/10.1073\/pnas.1303645110 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"26800_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/375291a0","volume":"375","author":"FA Rey","year":"1995","unstructured":"Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C. & Harrison, S. C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375, 291\u2013298, https:\/\/doi.org\/10.1038\/375291a0 (1995).","journal-title":"Nature"},{"key":"26800_CR21","unstructured":"Kabat, E. A., National Institutes of, H. & Columbia, U. Sequences of proteins of immunological interest. (U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1991)."},{"key":"26800_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.antiviral.2017.05.007","volume":"144","author":"EZ Ong","year":"2017","unstructured":"Ong, E. Z. et al. Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates. Antiviral Res 144, 44\u201347, https:\/\/doi.org\/10.1016\/j.antiviral.2017.05.007 (2017).","journal-title":"Antiviral Res"},{"key":"26800_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.meegid.2009.02.003","volume":"9","author":"SC Weaver","year":"2009","unstructured":"Weaver, S. C. & Vasilakis, N. Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease. Infect Genet Evol 9, 523\u2013540, https:\/\/doi.org\/10.1016\/j.meegid.2009.02.003 (2009).","journal-title":"Infect Genet Evol"},{"key":"26800_CR24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.meegid.2011.12.011","volume":"12","author":"RL Costa","year":"2012","unstructured":"Costa, R. L., Voloch, C. M. & Schrago, C. G. Comparative evolutionary epidemiology of dengue virus serotypes. Infect Genet Evol 12, 309\u2013314, https:\/\/doi.org\/10.1016\/j.meegid.2011.12.011 (2012).","journal-title":"Infect Genet Evol"},{"key":"26800_CR25","doi-asserted-by":"publisher","first-page":"8828","DOI":"10.1128\/JVI.00606-08","volume":"82","author":"GD Gromowski","year":"2008","unstructured":"Gromowski, G. D., Barrett, N. D. & Barrett, A. D. Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus. J Virol 82, 8828\u20138837, https:\/\/doi.org\/10.1128\/JVI.00606-08 (2008).","journal-title":"J Virol"},{"key":"26800_CR26","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1099\/vir.0.83028-0","volume":"88","author":"O Lisova","year":"2007","unstructured":"Lisova, O., Hardy, F., Petit, V. & Bedouelle, H. Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus. J Gen Virol 88, 2387\u20132397, https:\/\/doi.org\/10.1099\/vir.0.83028-0 (2007).","journal-title":"J Gen Virol"},{"key":"26800_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.virol.2008.11.013","volume":"384","author":"K Matsui","year":"2009","unstructured":"Matsui, K. et al. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III. Virology 384, 16\u201320, https:\/\/doi.org\/10.1016\/j.virol.2008.11.013 (2009).","journal-title":"Virology"},{"key":"26800_CR28","doi-asserted-by":"publisher","first-page":"e1000823","DOI":"10.1371\/journal.ppat.1000823","volume":"6","author":"B Shrestha","year":"2010","unstructured":"Shrestha, B. et al. The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog 6, e1000823, https:\/\/doi.org\/10.1371\/journal.ppat.1000823 (2010).","journal-title":"PLoS Pathog"},{"key":"26800_CR29","doi-asserted-by":"publisher","first-page":"7585","DOI":"10.1128\/JVI.00757-13","volume":"87","author":"G Fibriansah","year":"2013","unstructured":"Fibriansah, G. et al. Structural changes in dengue virus when exposed to a temperature of 37 degrees C. J Virol 87, 7585\u20137592, https:\/\/doi.org\/10.1128\/JVI.00757-13 (2013).","journal-title":"J Virol"},{"key":"26800_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep00200","volume":"1","author":"V Soundararajan","year":"2011","unstructured":"Soundararajan, V. et al. Networks link antigenic and receptor-binding sites of influenza hemagglutinin: mechanistic insight into fitter strain propagation. Sci Rep 1, 200, https:\/\/doi.org\/10.1038\/srep00200 (2011).","journal-title":"Sci Rep"},{"key":"26800_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep45886","volume":"7","author":"DS Quinlan","year":"2017","unstructured":"Quinlan, D. S. et al. An inter-residue network model to identify mutational-constrained regions on the Ebola coat glycoprotein. Sci Rep 7, 45886, https:\/\/doi.org\/10.1038\/srep45886 (2017).","journal-title":"Sci Rep"},{"key":"26800_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.virol.2015.08.011","volume":"485","author":"JC Frei","year":"2015","unstructured":"Frei, J. C., Kielian, M. & Lai, J. R. Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display. Virology 485, 371\u2013382, https:\/\/doi.org\/10.1016\/j.virol.2015.08.011 (2015).","journal-title":"Virology"},{"key":"26800_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1126\/science.7529940","volume":"267","author":"T Clackson","year":"1995","unstructured":"Clackson, T. & Wells, J. A. A hot spot of binding energy in a hormone-receptor interface. Science 267, 383\u2013386 (1995).","journal-title":"Science"},{"key":"26800_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0959-440X(02)00283-X","volume":"12","author":"WL DeLano","year":"2002","unstructured":"DeLano, W. L. Unraveling hot spots in binding interfaces: progress and challenges. Curr Opin Struct Biol 12, 14\u201320 (2002).","journal-title":"Curr Opin Struct Biol"},{"key":"26800_CR35","doi-asserted-by":"publisher","first-page":"5 6 1","DOI":"10.1002\/cpbi.3","volume":"54","author":"B Webb","year":"2016","unstructured":"Webb, B. & Sali, A. Comparative Protein Structure Modeling Using MODELLER. Curr Protoc Bioinformatics 54, 5 6 1\u20135 6 37, https:\/\/doi.org\/10.1002\/cpbi.3 (2016).","journal-title":"Curr Protoc Bioinformatics"},{"key":"26800_CR36","doi-asserted-by":"publisher","first-page":"W665","DOI":"10.1093\/nar\/gkh381","volume":"32","author":"TJ Dolinsky","year":"2004","unstructured":"Dolinsky, T. J., Nielsen, J. E., McCammon, J. A. & Baker, N. A. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res 32, W665\u2013667, https:\/\/doi.org\/10.1093\/nar\/gkh381 (2004).","journal-title":"Nucleic Acids Res"},{"key":"26800_CR37","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.1073\/pnas.181342398","volume":"98","author":"NA Baker","year":"2001","unstructured":"Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA 98, 10037\u201310041, https:\/\/doi.org\/10.1073\/pnas.181342398 (2001).","journal-title":"Proc Natl Acad Sci USA"},{"key":"26800_CR38","unstructured":"The PyMOL Molecular Graphics System (2002)."},{"key":"26800_CR39","unstructured":"Case, D. A. et al. (University of California, San Francisco, 2012)."},{"key":"26800_CR40","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics 79, 926\u2013935, https:\/\/doi.org\/10.1063\/1.445869 (1983).","journal-title":"The Journal of Chemical Physics"},{"key":"26800_CR41","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: An N\u22c5log(N) method for Ewald sums in large systems. The Journal of Chemical Physics 98, 10089\u201310092, https:\/\/doi.org\/10.1063\/1.464397 (1993).","journal-title":"The Journal of Chemical Physics"},{"key":"26800_CR42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"J-P Ryckaert","year":"1977","unstructured":"Ryckaert, J.-P., Ciccotti, G. & Berendsen, H. J. C. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. Journal of Computational Physics 23, 327\u2013341, https:\/\/doi.org\/10.1016\/0021-9991(77)90098-5 (1977).","journal-title":"Journal of Computational Physics"},{"key":"26800_CR43","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller","year":"2012","unstructured":"Miller, B. R. et al. MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. J Chem Theory Comput 8, 3314\u20133321, https:\/\/doi.org\/10.1021\/ct300418h (2012).","journal-title":"J Chem Theory Comput"},{"key":"26800_CR44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/minf.201100135","volume":"31","author":"N Homeyer","year":"2012","unstructured":"Homeyer, N. & Gohlke, H. Free Energy Calculations by the Molecular Mechanics Poisson-Boltzmann Surface Area Method. Mol Inform 31, 114\u2013122, https:\/\/doi.org\/10.1002\/minf.201100135 (2012).","journal-title":"Mol Inform"},{"key":"26800_CR45","unstructured":"Hubbard, S. J. & Thornton, J. M. NACCESS. Computer Program, Department of Biochemistry and Molecular Biology, http:\/\/www.bioinf.manchester.ac.uk\/naccess\/ (1993)."},{"key":"26800_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0022-2836(71)90324-X","volume":"55","author":"B Lee","year":"1971","unstructured":"Lee, B. & Richards, F. M. The interpretation of protein structures: estimation of static accessibility. J Mol Biol 55, 379\u2013400 (1971).","journal-title":"J Mol Biol"},{"key":"26800_CR47","doi-asserted-by":"crossref","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J Mol Graph 14, 33\u201338, 27\u201338 (1996).","DOI":"10.1016\/0263-7855(96)00018-5"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26800-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26800-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26800-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T06:02:22Z","timestamp":1671602542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26800-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,31]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["26800"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-26800-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,31]]},"assertion":[{"value":"4 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.S. is a founder, shareholder, and member of the board of Visterra, Inc, which is performing clinical evaluation of mAb 513. The other authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8449"}}